CAR T cells, immunologic and cellular therapies in hematologic malignancies

Best Pract Res Clin Haematol. 2018 Jun;31(2):115-116. doi: 10.1016/j.beha.2018.05.001. Epub 2018 May 18.

Authors

Renier Brentjens¹, Marco L Davila²

Affiliations

¹ Department of Medicine, Memorial Sloan Kettering Cancer Center, USA.
² Department of Blood & Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, USA. Electronic address: Marco.Davila@moffitt.org.

No abstract available

Publication types

Editorial

MeSH terms

Hematologic Neoplasms / immunology
Hematologic Neoplasms / therapy*
Humans
Immunotherapy, Adoptive / methods*
Receptors, Chimeric Antigen / therapeutic use*

Substances

Receptors, Chimeric Antigen

Grants and funding

K12 CA090625/CA/NCI NIH HHS/United States